New highly cited paper
Our Acta Pharmacologica Sinica paper describing the discovery of new immunotherapy-specific biomarkers has reached highly cited status in the Web of Science.
New online platform
We have released our new online platform developed to determine the advantage of chemotherapy in breast cancer by using AI methods and clinico-pathological data
New research paper
Menyhart O, Kothalawala WJ, Győrffy B: A gene set enrichment analysis for the cancer hallmarks, Journal of Pharmaceutical Analysis (2024)
Highly cited paper
Our epigenetic review desrcibing the methyaltion-based biomarkers in colorectal cancer has reached highly cited status in the Web of Science.
New review paper
Menyhart O et al.: Dietary approaches for exploiting metabolic vulnerabilities in cancer. BBA Reviews on Cancer (2024)
New research paper
Bartha A et al.: Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment response, Eur J Cancer (2023)
New research paper
Győrffy B: Transcriptome-level Discovery of Survival-Associated Biomarkers and Therapy Targets in Non-Small-Cell Lung Cancer, Brit J Pharmacol (2023)
New research paper
Wang XQ, Győrffy B, Bianchinig G, Ali RH et al: Single-cell spatial predictors of immunotherapy response in triple negative breast cancer, Nature (2023)
Web of Science
See all publications in
ELIXIR Hungary
Click logo to jump to the homepage of ELIXIR Hungary
OnkoBank
Click logo to jump to the OnkoBank homepage
Copyright 2024. All rights reserved
Designed by Zymphonies